Zuanic & Associates Managing Partner Pablo Zuanic Says Despite Positive Momentum And Fact We Have A Hearing Coming Up And Possibility Very Likely We Will Get Rescheduling We're Still At Seven; We're Not Seeing Consolidation Right Now Is It Goes Valuations Are So Depressed
Portfolio Pulse from Benzinga Newsdesk
Pablo Zuanic of Zuanic & Associates highlights the positive momentum in the cannabis sector, with an upcoming hearing and likely rescheduling. However, he notes that valuations remain depressed and consolidation is not occurring.
October 08, 2024 | 5:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
MSOS, a cannabis-focused ETF, may experience positive momentum due to the likely rescheduling of cannabis. However, the lack of consolidation and depressed valuations could limit immediate gains.
The likely rescheduling of cannabis is a positive regulatory development for MSOS, which focuses on cannabis stocks. However, the absence of consolidation and depressed valuations in the sector may temper short-term price increases.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80